Keyword
Menu
Home
About
Introducing Spineopedia
How We Score
Editors
Study Reviews
Resources
Spine Meetings
Calendar
Contact
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion procedure
Share
Posted:
June 13, 2019 at 11:39 am / by
admin
/
comments (0)
tags:
Keyword
Recent Comments
Recent Comments